Gene Therapies
-
{
- All
- News
-
New Gene Therapy Uses Harmless Virus To Target Muscle Spasms, Study Finds
The findings showed that animals receiving the treatment experienced a gradual reduction in muscle spasticity. Significant improvements began to appear several weeks after therapy and continued over time.
-
Scientists Develop Targeted Drug Delivery For Arresting Tumour Growth, Reducing Off-target Effects
Experiments in breast cancer models demonstrated a robust gene knockdown, resulting in an increased cancer cell death and a substantial inhibition in tumour growth.
-
Biotech Firm MedTherapy Says It Can Cut Gene Therapy Production Time To One Day
A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has significantly shortened the process.
-
New One-Shot Gene Editing Therapy May Reduce Bad Cholesterol By 62%
A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62% after a single infusion in an early trial, raising hopes for a long-lasting treatment to reduce heart attack risk
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
Scientists Restore Ancient Gene To Help Treat Gout And Uric Acid Disorders
Scientists at Georgia State University have revived a 20-million-year-old gene called uricase, which may offer new hope in treating gout and related uric acid disorders by helping the body break down excess uric acid naturally.
-
Bharat Biotech Invests Rs 645 Crore To Set Up Cell And Gene Therapy Unit In Telangana
Bharat Biotech sets up vertically integrated CGT facility in Telangana
-
Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinical trials published in The Lancet Haematology journal.
-
GST Council Exempts Gene Therapy, Cuts Tax Rate For Rice Kernels
Jaisalmer (Rajasthan): Union Finance Minister Nirmala Sitharaman on Saturday announced that the Goods and Services Tax Council has approved the reduction of GST on rice kernels to 5 per cent and exempted life-saving gene therapy from tax.
-
New Gene Therapy Uses Harmless Virus To Target Muscle Spasms, Study Finds
The findings showed that animals receiving the treatment experienced a gradual reduction in muscle spasticity. Significant improvements began to appear several weeks after therapy and continued over time.
-
Scientists Develop Targeted Drug Delivery For Arresting Tumour Growth, Reducing Off-target Effects
Experiments in breast cancer models demonstrated a robust gene knockdown, resulting in an increased cancer cell death and a substantial inhibition in tumour growth.
-
Biotech Firm MedTherapy Says It Can Cut Gene Therapy Production Time To One Day
A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has significantly shortened the process.
-
New One-Shot Gene Editing Therapy May Reduce Bad Cholesterol By 62%
A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62% after a single infusion in an early trial, raising hopes for a long-lasting treatment to reduce heart attack risk
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
Scientists Restore Ancient Gene To Help Treat Gout And Uric Acid Disorders
Scientists at Georgia State University have revived a 20-million-year-old gene called uricase, which may offer new hope in treating gout and related uric acid disorders by helping the body break down excess uric acid naturally.
-
Bharat Biotech Invests Rs 645 Crore To Set Up Cell And Gene Therapy Unit In Telangana
Bharat Biotech sets up vertically integrated CGT facility in Telangana
-
Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinical trials published in The Lancet Haematology journal.
-
GST Council Exempts Gene Therapy, Cuts Tax Rate For Rice Kernels
Jaisalmer (Rajasthan): Union Finance Minister Nirmala Sitharaman on Saturday announced that the Goods and Services Tax Council has approved the reduction of GST on rice kernels to 5 per cent and exempted life-saving gene therapy from tax.
